Zymeworks Inc expected to post a loss of 41 cents a share - Earnings Preview

Zymeworks

06/05/2025 21:32

Zymeworks Inc ZYME.OQ ZYME.O is expected to show a rise in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Middletown Delaware-based  company is expected to report a 105.9% increase in revenue to $20.653 million from $10.03 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Zymeworks Inc is for a loss of 41 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Zymeworks Inc is $19.50​, above​ its last closing price of $12.85. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.17
-0.10
-0.31
Missed
-213.1
Sep. 30 2024
-0.31
-0.40
-0.39
Beat
1.4
Jun. 30 2024
-0.33
-0.32
-0.27
Beat
14.7​
Mar. 31 2024
-0.29
-0.29
-0.42
Missed
-44.8
​​Dec. 31 2023
-0.46
-0.43
-0.20
Beat
53.9
Sep. 30 2023
-0.50
-0.47
-0.41
Beat
12.7​
Jun. 30 2023
-0.49
-0.47
-0.76
Missed
-61.6
Mar. 31 2023
-0.55
-0.54
-0.36
Beat
32.9

This summary was machine generated May 6 at 20:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)